- Patent Title: Pharmaceutical composition comprising epidithiodioxopiperazine compound or derivative thereof, or pharmaceutically acceptable salt thereof, for preventing or treating pulmonary hypertension
-
Application No.: US16315536Application Date: 2017-07-05
-
Publication No.: US10588910B2Publication Date: 2020-03-17
- Inventor: Sang Won Kang , Ki Hwan Kwon
- Applicant: VASTHERA CO. LTD.
- Applicant Address: KR Seoul
- Assignee: Vasthera Co. Ltd.
- Current Assignee: Vasthera Co. Ltd.
- Current Assignee Address: KR Seoul
- Agency: Seed IP Law Group LLP
- Priority: KR10-2016-0085040 20160705
- International Application: PCT/KR2017/007191 WO 20170705
- International Announcement: WO2018/008984 WO 20180111
- Main IPC: A61K31/548
- IPC: A61K31/548 ; A61P9/12 ; A61K31/407 ; C07D513/08 ; A61K31/549
Abstract:
The present invention relates to a pharmaceutical composition for preventing or treating pulmonary arterial hypertension, which comprises an epidithiodioxopiperazine (ETP) compound or a derivative thereof, or a pharmaceutically acceptable salt thereof.
Public/Granted literature
Information query
